Literature DB >> 3714620

The effect of oral digoxin on sodium excretion, renin-angiotensin-aldosterone system and blood pressure in normotensive subjects.

F P Cappuccio, N D Markandu, G A Sagnella, G A MacGregor.   

Abstract

The effect of digoxin (0.25 mg t.d.s.) given orally for 5 days, on sodium excretion, plasma renin activity, plasma aldosterone and blood pressure has been studied in 6 normotensive subjects, on a constant sodium intake. Average serum digoxin level measured in 5 subjects on the 5th day of treatment was in the upper range of the therapeutic level (1.92 +/- 0.3 nmol/l). Red cell sodium content increased from 9.75 +/- 1.2 mmol/l of cells in the control period to 15.3 +/- 1.7 mmol/l of cells on the 5th day of digoxin treatment when measured in 4 of the 6 subjects. In spite of this evidence of inhibition of the red cell sodium pump, there was no detectable change in sodium excretion, blood pressure, plasma renin activity and aldosterone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3714620      PMCID: PMC2418669          DOI: 10.1136/pgmj.62.726.265

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  17 in total

1.  Clinical experience with use of ultrasound sphygmomanometer.

Authors:  C F George; P J Lewis; A Petrie
Journal:  Br Heart J       Date:  1975-08

2.  STUDIES ON DIGITALIS. X. EFFECTS OF OUABAIN ON FOREARM VASCULAR RESISTANCE AND VENOUS TONE IN NORMAL SUBJECTS AND IN PATIENTS IN HEART FAILURE.

Authors:  D T MASON; E BRAUNWALD
Journal:  J Clin Invest       Date:  1964-03       Impact factor: 14.808

3.  Effect of ouabain on sodium flux in human red cells.

Authors:  T J GILL; A K SOLOMON
Journal:  Nature       Date:  1959-04-18       Impact factor: 49.962

4.  Hemodynamic effects of cardiac glycosides on normal human subjects during rest and exercise.

Authors:  M H WILLIAMS; L R ZOHMAN; A C RATNER
Journal:  J Appl Physiol       Date:  1958-11       Impact factor: 3.531

5.  The effect of intravenously administered digoxin on water and electrolyte excretion and on renal functions.

Authors:  S J FARBER; D J ALEXANDER; E D PELLEGRINO; D P EARLE
Journal:  Circulation       Date:  1951-09       Impact factor: 29.690

6.  Contractions of canine vascular smooth muscle cells caused by ouabain are due to release of norepinephrine from adrenergic nerve endings.

Authors:  L L Aarhus; J T Shepherd; G M Tyce; T J Verbeuren; P M Vanhoutte
Journal:  Circ Res       Date:  1983-05       Impact factor: 17.367

7.  Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage.

Authors:  J E Roulston; G A MacGregor
Journal:  Clin Chim Acta       Date:  1978-08-15       Impact factor: 3.786

8.  Digoxin-norepinephrine response and calcium blocker effects in vascular smooth muscle.

Authors:  S F Flaim; D J DiPette
Journal:  Am J Physiol       Date:  1979-04

9.  The erythrocyte sodium and potassium in patients treated with digoxin.

Authors:  D B Morgan; M Cumberbatch; S Cohn; D Scott; T Gunasuntharam; C Davidson; C Chapman
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

10.  Effects of digoxin on islated human mesenteric vessels.

Authors:  E Mikkelsen; K E Andersson; O L Pedersen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-07
View more
  1 in total

Review 1.  Age-related differences in digoxin toxicity and its treatment.

Authors:  T G Wells; R A Young; G L Kearns
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.